Cancer control: immunotherapy offers solution to a cure – Axios
Axios |
Cancer control: immunotherapy offers solution to a cure
Axios “The greatest excitement is reserved for immunotherapy, a new approach that has emerged in the past few years. The human immune system is equipped with a set of brakes that cancer cells are able to activate; the first immunotherapy treatment in effect … |
Labiotech.eu (blog) |
Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
Labiotech.eu (blog) With the microbiome already gaining traction in the therapeutics field, Bayer has decided to take it to agriculture. In partnership with US synthetic biology upstart Ginkgo Bioworks, the German giant is creating a new company to engineer plant … |
|
$11.6 Million NIH Grant Supports Temple Researchers’ Exploration of New Cell-Free Stem Cell-Based Possibilities in …
Newswise (press release) Newswise — The incidence of heart disease is on the rise, and new therapeutic strategies are needed. Approaches based on stem cells, which can potentially preserve or even regenerate heart muscle cells damaged by ischemia – a hallmark of heart … Mesenchymal Stem Cells Market to Observe Strong Development by 2020satPRnews (press release) |
|
Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
Medical Xpress A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery. A comprehensive … |
|
OncBioMune Meets Primary Objective in Trial of ProscaVax Immunotherapy Vaccine for Prostate Cancer
Markets Insider ProscaVax is OncBioMune’s novel immunotherapeutic cancer vaccine consisting of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF). The study … |